Myeloid cell GM-CSF, STAT5, and prostaglandin synthase 2 (PGS2/COX2) expression in nonobese diabetic (NOD) mice

被引：0
|
作者：
Litherland, SA
Elf, J
Paek, E
Clare-Salzler, MJ
McDuffie, M
机构：
[1] Univ Florida, Coll Med, Gainesville, FL 32610 USA
[2] Univ Virginia, Coll Med, Charlottesville, VA USA
来源：
FASEB JOURNAL | 2003年 / 17卷 / 07期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：C36 / C36
页数：1
相关论文
共 50 条
  • [1] Persistent STAT5 Phosphorylation and Epigenetic Dysregulation of GM-CSF and PGS2/COX2 Expression in Type 1 Diabetic Human Monocytes
    Garrigan, Erin
    Belkin, Nicole S.
    Alexander, John J.
    Han, Zhao
    Seydel, Federica
    Carter, Jamal
    Atkinson, Mark
    Wasserfall, Clive
    Clare-Salzler, Michael J.
    Amick, Matthew A.
    Litherland, Sally A.
    PLOS ONE, 2013, 8 (10):
  • [2] Epigenetic Dysfunction in Autoimmune Diabetes: Persistent Monocyte STAT5 Phosphorylation Promotes Epigenetic Dysregulation of GM-CSF-Induced PGS2/COX2 Expression in Type 1 Diabetes
    Han, Zhao
    Garrigan, Erin
    Atkinson, Mark
    Wasserfall, Clive
    Clare-Salzler, Michael J.
    Amick, Matthew
    Litherland, Sally A.
    DIABETES, 2010, 59 : A58 - A58
  • [3] M-CSF and GM-CSF Regulation of STAT5 Activation and DNA Binding in Myeloid Cell Differentiation is Disrupted in Nonobese Diabetic Mice
    Rumore-Maton, B.
    Elf, J.
    Belkin, N.
    Stutevoss, B.
    Seydel, F.
    Garrigan, E.
    Litherland, S. A.
    CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2008,
  • [4] GM-CSF induces STAT5 binding at epigenetic regulatory sites within the Csf2 promoter of non-obese diabetic (NOD) mouse myeloid cells
    Seydel, F.
    Garrigan, E.
    Stutevoss, B.
    Belkin, N.
    Makadia, B.
    Carter, J.
    Shi, J. -D.
    Davoodi-Semiromi, A.
    McDuffie, M.
    Litherland, S. A.
    JOURNAL OF AUTOIMMUNITY, 2008, 31 (04) : 377 - 384
  • [5] CONTROL OF PROSTAGLANDIN SYNTHASE-2 (PGS-2) EXPRESSION IN NOD MACROPHAGES
    XIE, T
    YUI, M
    HOFIG, A
    REDDY, S
    HERSCHMAN, H
    WAKELAND, E
    CLARESALZLER, M
    DIABETES, 1995, 44 : A240 - A240
  • [6] Aberrant monocyte prostaglandin synthase-2 (PGS2) expression; A novel cellular marker for IDD risk
    Litherland, SA
    Xie, TX
    Whittaker, DS
    Hutson, AD
    Schatz, D
    Moldawer, LL
    Clare-Salzler, MJ
    DIABETES, 1998, 47 : A215 - A215
  • [7] Expression of prostaglandin H-synthase (COX2) in osteoid osteoma
    Lucio, E
    Ololade, O
    Adegboyega, PA
    LABORATORY INVESTIGATION, 2001, 81 (01) : 15A - 15A
  • [8] Expression of prostaglandin H-synthase (COX2) in osteoid osteoma
    Lucio, E
    Ololade, O
    Adegboyega, PA
    MODERN PATHOLOGY, 2001, 14 (01) : 15A - 15A
  • [9] Expression of prostaglandin H-synthase (COX2) in lesions of the uterine cervix
    Garcia, MK
    Adegboyega, PA
    LABORATORY INVESTIGATION, 2003, 83 (01) : 190A - 190A
  • [10] Carboxy-terminal truncated STAT5 is induced by interleukin-2 and GM-CSF in human neutrophils
    Epling-Burnette, PK
    Garcia, R
    Bai, FQ
    Ismail, S
    Loughran, TP
    Djeu, JY
    Jove, R
    Wei, S
    CELLULAR IMMUNOLOGY, 2002, 217 (1-2) : 1 - 11
12345